Partner
Dandan Dong
MANAGING PARTNER, TCG Crossover
- Firm
- TCG Crossover
- Title
- MANAGING PARTNER
- Role
- Managing partner
- Known as
- Investor
Claim, correct or request removal
Record updated 17 September 2026
About
Dr. Dandan Dong joined TCGX as a venture partner to lead the venture formation effort. She brings over 15 years of global healthcare investment and biotech operating experience. Before joining TCGX, she served as the Chief Business Officer of ArriVent Biopharma, where she played an essential role in company formation and led the acquisition of the ex-China rights of the core asset, furmonertinib. She was also instrumental in the company’s private and public financing activities. Prior to that, Dr. Dong was the Managing Director of Vivo Capital, the General Partner of Vivo PANDA Fund and Innovation Fund II.
Is this you? Remove my profile
Loading relationship preview